Earnings Call · Q2 FY2026·2026-08-03

Q2 26EPS +1.20%·Rev n/aQ1 26EPS +3.81%·Rev n/aQ4 25EPS -2.33%·Rev n/aQ3 25EPS +4.80%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President of Investor Relations

Reshma Kewalramani — CEO and President

Duncan McKechnie — Chief Commercial Officer

Charlie Wagner — Chief Operating Officer and Chief Financial Officer

spk10

+1.7%1d on move date3d+2.8%5d+11.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access